Related references
Note: Only part of the references are listed.Combined Restitutive Therapy for Treatment of Immunosuppressive Refractory Crohn Disease
Jason R. Goldsmith et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Intestinal Epithelial Cell-Derived μ-Opioid Signaling Protects against Ischemia Reperfusion Injury through PI3K Signaling
Jason R. Goldsmith et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Yehuda Ringel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease
Kevin Whelan et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Glafenine-induced intestinal injury in zebrafish is ameliorated by μ-opioid signaling via enhancement of Atf6-dependent cellular stress responses
Jason R. Goldsmith et al.
DISEASE MODELS & MECHANISMS (2013)
Consumption of Fermented Milk Product With Probiotic Modulates Brain Activity
Kirsten Tillisch et al.
GASTROENTEROLOGY (2013)
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
Delphine M. Saulnier et al.
GUT MICROBES (2013)
Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications
Fredrik Backhed et al.
CELL HOST & MICROBE (2012)
Consumption of probiotics increases the effect of regulatory T cells in transfer colitis
Emil Rathsach Petersen et al.
INFLAMMATORY BOWEL DISEASES (2012)
Targeting the Intestinal Microbiota in the Pediatric Population: A Clinical Perspective
Tamar Ringel-Kulka
NUTRITION IN CLINICAL PRACTICE (2012)
Mu Opioid Signaling Protects Against Acute Murine Intestinal Injury in a Manner Involving Stat3 Signaling
Jason R. Goldsmith et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome
Yehuda Ringel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders A Double-blind Study
Tamar Ringel-Kulka et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects
Peter Holzer
CURRENT OPINION IN ANESTHESIOLOGY (2010)
Effect of a Probiotic Preparation (VSL# 3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis
Erasmo Miele et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility
Joshua M. Uronis et al.
PLOS ONE (2009)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Christel Rousseaux et al.
NATURE MEDICINE (2007)
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation
D. Philippe et al.
GUT (2006)
Diversity and complexity of the mu opioid receptor gene: Alternative pre-mRNA splicing and promoters
YX Pan
DNA AND CELL BIOLOGY (2005)
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation
D Philippe et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic
ME Sanders et al.
JOURNAL OF DAIRY SCIENCE (2001)
Share Paper
